Beyond the Infusion Chair: The Subcutaneous Immunotherapy Shift

Podcast | English | 2025 | 45 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

This episode of Lung Cancer Considered reviews new and upcoming approvals for subcutaneous immune checkpoint inhibitors. Join host Dr. Narjust Florez and guests, Dr. Cheryl Ho and Dr. Maria Velez Velez, for a discussion of the formulation and its place in the management of patients with lung cancer.

Podcast Hosts:

Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, Boston, MA, USA

Podcast Guests:

Cheryl Ho, MD, FRCPC, Thoracic Oncologist, BC Cancer, Clinical Associate Professor and Fellowship Program Director, University of British Columbia, Vancouver, BC, Canada
Maria Velez Velez, MD, MS, Clinical Instructor, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA